Literature DB >> 24477491

Unusual features of Creutzfeldt-Jakob disease followed-up in a memory clinic.

Agnès Jacquin1, Vincent Deramecourt, Serge Bakchine, Claude-Alain Maurage, Florence Pasquier.   

Abstract

Sporadic Creutzfeldt-Jakob disease (sCJD) generally manifests itself by cognitive or rapidly progressive motor symptoms. An atypical onset or an unusual evolution may delay the diagnosis. Among patients with a confirmed diagnosis of sCJD following a post-mortem neuropathological examination at the Neuropathology Centre of Lille, France, those who had presented with atypical cognitive disorders at onset were included in the study. Four patients were included. The first patient (64-years-old) presented early language disorders, later accompanied by apathy and behavioral disorders. The prolonged course suggested a diagnosis of progressive primary aphasia. The second patient (68-years-old) presented with aphasia, apraxia, and ataxia of the right upper limb with parkinsonian syndrome, suggesting corticobasal degeneration. In the two last patients (58- and 61-years-old), the onset was marked by an anxiety-depression syndrome, falls, visual hallucinations, extra-pyramidal syndrome, and fluctuating cognitive decline. The diagnosis raised was probable Lewy body dementia. The 14.3.3 protein was found in two of the four cases. The clinical elements found may initially suggest focal atrophy or Lewy body dementia. A very rapid clinical deterioration generally suggests sCJD, but in the last case, the evolution was particularly slow. The diagnosis of sCJD must be considered in cases of rapid-onset dementia, even if all of the clinical criteria are not present. The detection of the 14.3.3 protein and multifold increase in total-Tau with normal or slightly increased phosphorylated-Tau in the CSF are additional arguments to reinforce the diagnosis. The post-mortem neuropathological examination is important to confirm the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477491     DOI: 10.1007/s00415-014-7246-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

Review 1.  Prion diseases.

Authors:  R S G Knight; R G Will
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

2.  Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Taim Muayqil; Gary Gronseth; Richard Camicioli
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

3.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

4.  Distinct neuropsychological characteristics in Creutzfeldt-Jakob disease.

Authors:  J S Snowden; D M A Mann; D Neary
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

5.  CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.

Authors:  P Sanchez-Juan; A Green; A Ladogana; N Cuadrado-Corrales; R Sáanchez-Valle; E Mitrováa; K Stoeck; T Sklaviadis; J Kulczycki; K Hess; M Bodemer; D Slivarichová; A Saiz; M Calero; L Ingrosso; R Knight; A C J W Janssens; C M van Duijn; I Zerr
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

6.  Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Authors:  M Otto; H Esselmann; W Schulz-Shaeffer; M Neumann; A Schröter; P Ratzka; L Cepek; I Zerr; P Steinacker; O Windl; J Kornhuber; H A Kretzschmar; S Poser; J Wiltfang
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

7.  A case of Creutzfeldt-Jakob disease mimicking corticobasal degeneration: FDG PET, SPECT, and MRI findings.

Authors:  Yuyang Zhang; Satoshi Minoshima; Hubert Vesselle; David H Lewis
Journal:  Clin Nucl Med       Date:  2012-07       Impact factor: 7.794

8.  Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease.

Authors:  J A Hainfellner; J Wanschitz; K Jellinger; P P Liberski; F Gullotta; H Budka
Journal:  Acta Neuropathol       Date:  1998-08       Impact factor: 17.088

9.  Rapidly progressive neurodegenerative dementias.

Authors:  Keith A Josephs; J Eric Ahlskog; Joseph E Parisi; Bradley F Boeve; Brian A Crum; Caterina Giannini; Ronald C Petersen
Journal:  Arch Neurol       Date:  2009-02

Review 10.  An overview of human prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-12-24       Impact factor: 4.099

View more
  3 in total

1.  Wernicke-Korsakoff syndrome as a rare phenotype of sporadic Creutzfeldt-Jakob disease.

Authors:  Joanna Bielewicz; Anna Szczepańska-Szerej; Magdalena Ogórek; Piotr Dropko; Katarzyna Wojtal; Konrad Rejdak
Journal:  Prion       Date:  2018-02-09       Impact factor: 3.931

2.  The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature.

Authors:  Diana Caine; Akin Nihat; Philippa Crabb; Peter Rudge; Lisa Cipolotti; John Collinge; Simon Mead
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

Review 3.  Biomarkers for sporadic Creutzfeldt-Jakob disease.

Authors:  Sanam Soomro; Chandra Mohan
Journal:  Ann Clin Transl Neurol       Date:  2016-04-25       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.